Baxter International | BAX - Ordinary Share Capital


Baxter International reported $517M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 50.64M 7K Jun/2026
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 377.4M 8.5M Jun/2026
Edwards Lifesciences USD 577M 3.7M Mar/2026
Fresenius EUR 563.24M 0 Dec/2025
Globus Medical USD 135.67M 611K Mar/2026
Halozyme Therapeutics USD 118.52M 741K Mar/2026
ICU Medical USD 24.69M 2K Dec/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
Intuitive Surgical USD 354.16M 1.01M Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Laboratory Of America USD 80.9M 1.4M Jun/2026
Medtronic USD 1.28B 1.38M Dec/2025
Merit Medical Systems USD 59.71M 55K Jun/2026
Quest Diagnostics USD 110M 1000K Jun/2026
Smith & Nephew USD 875.95M 11.64K Jun/2026
Stryker USD 383.4M 416K Jun/2026
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.26M 70K Mar/2026
Terumo JPY 1.48B 11K Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026